SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

被引：0

作者：

Alonso-Gordoa, Teresa ^{[1
]}

Jimenez-Fonseca, Paula ^{[2
]}

Martinez-Trufero, Javier ^{[3
]}

Navarro, Miguel ^{[4
]}

Porras, Ignacio ^{[5
]}

Rubio-Casadevall, Jordi ^{[6
]}

Arregui Valles, Marta ^{[7
]}

Baste, Neus ^{[8
]}

Hernando, Jorge ^{[9
]}

Iglesias Docampo, Lara ^{[10
]}

机构：

[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain

[2] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain

[3] Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain

[4] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain

[5] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Med Oncol Dept, Cordoba, Spain

[6] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona Biomed Res Inst IDIBGI, Med Oncol Dept,ONCOGIRPRO Grp, Girona, Spain

[7] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain

[8] Hosp Clin Barcelona, Med Oncol Dept, IDIBAPS, Barcelona, Spain

[9] Hosp Univ Vall DHebron, Med Oncol Dept, Gastrointestinal & Endocrine Tumor Unit, VHIO, Barcelona, Spain

[10] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Thyroid carcinoma; Molecular alterations; Multidisciplinary; Systemic treatment; PHASE-II TRIAL; ASSOCIATION GUIDELINES; DOUBLE-BLIND; LOCOREGIONAL RECURRENCE; RISK STRATIFICATION; NECK DISSECTION; OPEN-LABEL; CARCINOMA; MANAGEMENT; PAPILLARY;

D O I：

10.1007/s12094-024-03736-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.

引用

页码：2902 / 2916

页数：15

共 50 条

[31] SEOM clinical guideline for the management of cutaneous melanoma (2020)
Majem, M.
Manzano, J. L.
Marquez-Rodas, I.
Mujika, K.
Munoz-Couselo, E.
Perez-Ruiz, E.
de la Cruz-Merino, L.
Espinosa, E.
Gonzalez-Cao, M.
Berrocal, A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (05) : 948 - 960
[32] SEOM clinical guideline for the management of malignant melanoma (2017)
Berrocal, A.
Arance, A.
Castellon, V. E.
de la Cruz, L.
Espinosa, E.
Cao, M. G.
Larriba, J. L. G.
Marquez-Rodas, I.
Soria, A.
Algarra, S. M.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 69 - 74
[33] SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
Fernandez-Montes, Ana
Alcaide, Julia
Alsina, Maria
Belen Custodio, Ana
Fernandez Franco, Lourdes
Gallego Plazas, Javier
Gomez-Martin, Carlos
Richart, Paula
Rivera, Fernando
Martin-Richard, Marta
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04) : 658 - 669
[34] SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
Castillon, Jaume Capdevila
Gordoa, Teresa Alonso
Bayonas, Alberto Carmona
Carretero, Ana Custodio
Garcia-Carbonero, Rocio
Pulido, Enrique Grande
Fonseca, Paula Jimenez
Lete, Angela Lamarca
Huerta, Angel Segura
Plazas, Javier Gallego
CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (09) : 2692 - 2706
[35] SEOM clinical guidelines for cervical cancer (2019)
de Juan, A.
Redondo, A.
Rubio, M. J.
Garcia, Y.
Cueva, J.
Gaba, L.
Yubero, A.
Alarcon, J.
Maximiano, C.
Oaknin, A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02) : 270 - 278
[36] SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023)
Pericay, Carles
Montagut, Clara
Reina, Juan Jose
Melian, Marcos
Alcaide, Julia
Tarazona, Noelia
Ruiz-Casado, Ana
Gonzalez-Flores, Encarnacion
Grana, Begona
Gravalos, Cristina
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2812 - 2825
[37] SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)
Valderrama, Begona P.
Gonzalez-del-Alba, Aranzazu
Morales-Barrera, Rafael
Pelaez Fernandez, Ignacio
Vazquez, Sergio
Caballero Diaz, Cristina
Domenech, Montserrat
Fernandez Calvo, Ovidio
de Liano Lista, Alfonso Gomez
Arranz Arija, Jose Angel
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04) : 613 - 624
[38] A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules
Lee, Eun Kyung
Park, Young Joo
Jung, Chan Kwon
Na, Dong Gyu
ENDOCRINOLOGY AND METABOLISM, 2024, 39 (01) : 61 - 72
[39] SEOM Clinical Guideline for bone metastases from solid tumours (2016)
Gravalos, C.
Rodriguez, C.
Sabino, A.
Segui, M. A.
Virizuela, J. A.
Carmona, A.
Cassinello, J.
Isla, D.
Jara, C.
Martin, M.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12) : 1243 - 1253
[40] SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
Serrano, Cesar
Alvarez, Rosa
Carrasco, Juan Antonio
Marquina, Gloria
Martinez-Garcia, Jeronimo
Martinez-Marin, Virginia
Sala, Maria angeles
Sebio, Ana
Sevilla, Isabel
Martin-Broto, Javier
CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (09) : 2707 - 2717

← 1 2 3 4 5 →